The Latest Cardiac and Vascular News
VANCOUVER, BRITISH COLUMBIA — (Marketwired) — Feb 14, 2018 — Novoheart(“Novoheart” or the “Company”) (TSX VENTURE: NVH), through its wholly owned US subsidiary, has entered into a commercial agreement with Sumocor LLC(“Sumocor”), a biotech company based in New York City that is focused on the development of therapeutics for cardiovascular diseases. Pursuant to […]
VANCOUVER, BRITISH COLUMBIA — (Marketwired) — Jan 16, 2018 — Novoheart(“Novoheart” or the “Company”) (TSX VENTURE: NVH) today announced that it has filed a provisional patent application with the United States Patent and Trademark Office (USPTO) for a three-tiered drug screening system with enhanced capability, sensitivity and accuracy for detecting pharmacological effects […]
IRVINE, CALIFORNIA — (Marketwired) — Oct 25, 2017 — Novoheart (“Novoheart” or the “Company”) (TSX VENTURE: NVH), a global stem cell biotechnology company, is pleased to announce that it has opened a new US location in The Cove at UC Irvine, California. The Cove is home to UCI Applied Innovation – a public-private […]
